Skip to main content

Table 1 Distribution of cases between disease groups with the corresponding success rate

From: The added value of WES reanalysis in the field of genetic diagnosis: lessons learned from 200 exomes in the Lebanese population

Pathologies

Number of patients presenting the pathology

Number of patients with established molecular diagnosis

Percentage of patients with established molecular diagnosis (%)

Neurodevelopmental disorders

79

24

30.4

Neuromuscular disorders

20

17

85

Metabolic and mitochondrial disorders

19

16

84.2

Renal disorders

10

6

60

Hearing disorders

7

7

100

Epilepsy

6

4

66.7

Bone diseases

4

3

75

Leukodystrophy

4

3

75

Visual disorders

2

2

100

Others

49

30

61.2

Total

200

112

56